Rationale: Acute kidney injury may contribute to distant organ dysfunction. Few studies have examined kidney injury as a risk factor for delirium and coma.
long-term cognitive impairment in survivors of critical illness (8) (9) (10) (11) (12) (13) (14) (15) .
One mechanism by which acute kidney injury may contribute to poor outcomes is through effects on distant organ function (16) (17) (18) (19) (20) (21) (22) . Recent experimental data indicate that acute kidney injury can lead to inflammation in the brain and other remote organs (19, 21, 23) . In addition, loss of kidney function can reduce the clearance of medications, metabolites, or other potential neurotoxins. To date, only one study has examined the association between kidney dysfunction and delirium during critical illness (24) , which was limited by use of a single threshold for defining kidney dysfunction (i.e., serum creatinine .2 mg/dl), did not distinguish between acute and chronic disease, and was unable to describe the temporal relationship between acute kidney injury and delirium.
We hypothesized that acute kidney injury during critical illness is associated with delirium and coma in the ICU. We also hypothesized that renal replacement therapy would modify the association between an acute change in serum creatinine and delirium and coma. To test these hypotheses, we examined the relationship between acute kidney injury and cognitive dysfunction in the BRAIN-ICU (Bringing to Light the Risk Factors and Incidence of Neuropsychological Dysfunction in ICU Survivors) study (10) , a multicenter, prospective cohort study of critically ill adults with frequent (i.e., daily) assessments of both kidney and neurologic function.
Methods Study Population and Setting
This is a secondary analysis of the BRAIN-ICU study, a prospective cohort study of patients with acute respiratory failure and/or shock (cardiogenic or septic) enrolled at Vanderbilt University and Saint Thomas Hospital in Nashville, Tennessee between 2007 and 2010 (10) . We excluded patients with recent critical illness, could not be assessed for delirium, unlikely to survive 24 hours, or at high risk for preexisting cognitive deficits. For the current study, we only included patients enrolled at Vanderbilt because this was the only site with daily serum creatinine data available. We also excluded patients without any serum creatinine measurements, sequential organ failure assessment (SOFA), or mental status assessments available; participants receiving chronic renal replacement therapy; or with a baseline estimated glomerular filtration rate less than 20 ml/min/1.73 m 2 . We obtained written informed consent from all participants or their surrogates, which allowed for additional data abstraction from the electronic health record, and the study protocol was approved by the Vanderbilt institutional review board.
Data Collection
Exposures. We identified acute kidney injury using serum creatinine values measured during clinical care, determining daily severity with the creatinine-based arm of the Kidney Disease Improving Global Outcomes (KDIGO) system (25) , as follows:
1. Stage 1 injury: >0.3 mg/dl or 50% increase from baseline creatinine 2. Stage 2 injury: >100% increase in baseline serum creatinine 3. Stage 3 injury: >200% increase in baseline serum creatinine or receipt of renal replacement therapy
Because the KDIGO stage 1 definition is very sensitive, small, brief increases in creatinine are classified as acute kidney injury. Thus, we also conducted a sensitivity analysis that required sustained acute kidney injury in the definition of stage 1 injury. Specifically, we defined sustained stage 1 injury as an increase from baseline creatinine of greater than or equal to 0.3 mg/dl or 50% (and ,100%) after a day of stage 1 or greater acute kidney injury.
We estimated baseline creatinine as the mean outpatient serum creatinine 7-365 days before admission (26) . If baseline serum creatinine was greater than 0.5 mg/dl higher than the lowest creatinine during hospitalization (n = 13), two nephrologists (E.D.S. and W.H.F.) blinded to outcomes reviewed medical records and determined an adjudicated baseline creatinine. If preadmission creatinine was not available, we used the minimum serum creatinine during hospitalization. We verified the date and time of renal replacement therapy initiation and cessation with manual chart review and considered all days between initiation and cessation to be renal replacement therapy days unless renal replacement therapy was stopped greater than 72 hours. All creatinine data were collected retrospectively from the electronic medical record.
Outcomes. Trained research personnel used validated instruments to evaluate patients prospectively for delirium and coma twice daily until ICU discharge and then once daily until hospital discharge, study day 30, or death. Patients were assessed for delirium using the Confusion Assessment Method for the ICU (CAM-ICU) (27) , and level of consciousness (coma) was assessed using the Richmond Agitation-Sedation Scale (RASS) (28, 29) . We considered any day during which one or more CAM-ICU assessments were positive to be a day of delirium, and any day during which all RASS assessments were 24 (response only to physical stimulation) or 25 (no response to voice or physical stimulation) to be a day of coma (10) . We classified days during which neither delirium nor coma were present to be normal mental status days.
Covariates. Covariates were collected prospectively and included age, sex, race, severe sepsis (30) , modified SOFA score (31) , previous day's mental status, and sedative exposure during the previous day. We modified the SOFA score (which was
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Field: Acute kidney injury is shown to be associated with delirium and coma during critical illness after adjusting for potential confounders. This suggests kidney injury is an underappreciated risk factor that is important in the pathogenesis of delirium and coma during critical illness. calculated using organ failure data from the same day that the outcome was assessed) by subtracting out the neurologic and renal scores because these factors were already represented by our primary outcome and exposure, respectively. Points for respiratory, circulatory, hepatic, and coagulation systems were included for a total possible score of 0-16. Sedative exposure was examined both as daily dose (milligram of midazolam equivalents, microgram of fentanyl equivalents, and milligram of propofol) and as weightbased dose (daily dose by admission weight in kilogram).
Statistical Analyses
A detailed description of our statistical approach is provided in the online supplement. Briefly, we analyzed associations between acute kidney injury and mental status using first-order multinomial transition models that estimate the probability of each mental status outcome (normal, delirium, and coma) as a function of the previous day's mental status, current acute kidney injury status, and all covariates. A priori, we chose to model acute kidney injury in two ways: one model uses KDIGO stage to represent severity of acute kidney injury, and another uses daily peak serum creatinine (adjusted for baseline creatinine) to represent acute kidney injury severity. As described in detail in the online supplement, we also examined whether the association between acute kidney injury and mental status was modified by (i.e., interacted with) sedative exposure or renal replacement therapy and conducted several subgroup analyses, including analyses of patient-days after days when no sedative was given, patients who never received benzodiazepines during the study period, patients with known preadmission serum creatinine values, and patients without delirium or coma on study day 1. We performed analyses with R version 3. 
Results

Population Characteristics
Of 521 patients enrolled in the BRAIN-ICU study at Vanderbilt University Medical Center, three had no creatinine values measured, 40 were excluded because of preexisting severe kidney disease, 11 were excluded because of missing outcome or covariate data, and one patient withdrew from the study such that 466 patients were included in the current study (Figure 1 ). Subject characteristics and hospital outcomes are shown in Table 1 . Sepsis and acute respiratory distress syndrome were the most common admission diagnoses. Mechanical ventilation and sedation were common early during the study period but lasted only several days or less for most patients.
Baseline kidney function was normal for most patients, with the median baseline estimated glomerular filtration rate being 79 (54-99) ml/min/1.73 m 2 . The overall incidence of acute kidney injury during the 30 days after enrollment was 65% with more than half of patients having moderate-to-severe kidney injury and 1 in 10 receiving renal replacement therapy. Of the 50 patients who received renal replacement therapy, only 34 (68%) received their initial renal replacement therapy during the study period, with 21 (62%) receiving continuous renal replacement therapy or slow low-efficiency dialysis and 13 (38%) starting with conventional intermittent hemodialysis.
Seventy-five percent of patients experienced delirium at least once during the follow-up period, 60% experienced coma at least once, and 47% experienced both. However, of 5,056 total patient-days included in the study, mental status was normal during 2,672 (52.8%), delirious during 1,655 (32.5%), and comatose during 740 (14.6%).
Association between Acute Kidney Injury and Delirium or Coma
Throughout the study period, the proportion of patients with acute kidney injury differed according to mental status. Acute kidney injury was present on 37% of study days when patients had a normal mental status, on 50% of days when patients were delirious, and on 65% of days when patients were comatose.
Because our results suggest that renal replacement therapy modifies the association between acute kidney injury and mental status, we present the association between KDIGO stage and delirium and coma first among only those study days that did not involve renal replacement therapy. Only 10% of the cohort received renal replacement therapy during the study period. After adjusting for demographic factors, nonrenal organ failure, severe sepsis, and the previous day's mental status and sedative exposure, acute kidney injury as measured by KDIGO stage was a risk factor for both delirium and coma during non-renal replacement therapy days ( Table 3 and Figures 2D -2F, the model that included all study days (both non-renal replacement therapy and renal replacement therapy days) also found acute kidney injury was a significant risk factor for delirium and coma, but the associations between KDIGO stage 3 (which, by definition, included all renal replacement therapy days) and both delirium (OR, 1.48; 95% CI, 1.00-2.16) and coma (OR, 1.79; 95% CI, 1.11-2.91) were attenuated compared with those observed on non-renal replacement therapy days. Similar to the KDIGO analysis, acute kidney injury as measured by peak serum creatinine was a risk factor for delirium and coma after adjusting for covariates, including baseline creatinine, and the association differed according to whether or not the patient received renal replacement therapy on the date in question (Table 4 , Figure 3 show this interaction). Among patients not on renal replacement therapy, an increase in daily peak serum creatinine of 1 mg/dl was significantly associated with an increased odds of delirium (OR, 1.35; 95% CI, 1.18-1.55) and coma (OR, 1.44; 95% CI, 1.20-1.74), after adjusting for covariates. Among patients receiving renal replacement therapy, daily peak serum creatinine was not associated with delirium (OR, 1.07; 95% CI, 0.87-1.31) or coma (OR, 1.16; 95% CI, 0.94-1.44).
Supporting Analyses
An analysis using weight-based sedative doses yielded results that were nearly identical to those of our primary analysis (see Table E1 in the online supplement). In addition, among the subgroup of 2,286 patient-days where sedatives were not administered the previous day, we observed dose-dependent associations between KDIGO stages 1, 2, and 3 acute kidney injury and both delirium (OR, 1.32; 95% CI, 0.93-1.89) (OR, 1.79; 95% CI, 0.96-3.34) (OR, 2.48; 95% CI, 1.26-4.90) and coma (OR, 1.46, 95% CI, 0.82-2.60) (OR, 2.71; 95% CI, 1.13-6.49) (OR, 3.60; 95% CI, 1.01-12.84) that were similar to those observed when analyzing all patient-days. The associations between acute kidney injury and delirium and coma observed among the 166 patients who never received benzodiazepines during the study period were also similar to those observed in the full cohort (see Table E2 ). Lastly, we did not find any evidence of an interaction between KDIGO and sedative doses as risk factors for delirium (P values for the interaction were 0.45 and 0.47 in models with and without renal replacement therapy days, respectively).
Details regarding the number of patients for whom baseline creatinine measurements were available versus estimated are provided in the online supplement as are the results of sensitivity analyses showing that the associations between acute kidney injury and mental status were similar among those with baseline creatinine measurements versus those with estimated baselines. According to a likelihood ratio test (P = 0.95), there was no evidence that cases requiring an imputation of baseline creatinine had any differential data patterns of consequence.
Requiring that stage 1 acute kidney injury be sustained (i.e., be present on the previous day and the day of outcome assessment) did not substantially change the results. We found no statistically significant association between sustained stage 1 acute kidney injury and delirium (OR, 1.11; 95% CI, 0.88-1.41) or coma (OR, 1.15; 95% CI, 0.83-1.59).
Lastly, in an exploratory subgroup analysis limited to 132 patients without delirium or coma on study day 1, the associations between acute kidney injury and delirium and coma were consistent with the primary analysis indicating that KDIGO stages 2 and 3 were associated with an increased risk for delirium and trended in a similar direction for coma (see Table E3 ).
Discussion
In this large, prospective cohort of critically ill adults, moderate-to-severe acute kidney injury was strongly associated with delirium and coma after adjusting for numerous potential confounders. Furthermore, renal replacement therapy modified the association between acute changes in serum creatinine and acute brain dysfunction. These data are consistent with the hypothesis that acute kidney injury contributes to distant organ dysfunction during critical illness and raise the question of what modifiable risk factors for delirium and coma may underlie these associations. The mechanisms underlying the effects of acute kidney injury on the brain and other contributors in this population should be examined in future studies.
The observation that patients who die with acute kidney injury often do so with concomitant nonrenal organ failure has led to the hypothesis that acute kidney injury contributes to poor outcomes via signals that promote dysfunction and failure of other organs (6, 32) . Although not well studied in humans, experimental acute kidney injury leads to inflammation in the cerebral cortex and hippocampus that is associated with histologic changes and locomotor dysfunction (18, 19, 21, 23) . Other animal model studies have shown lung inflammation increases and vascular capillary permeability worsens with experimentally induced acute kidney injury (18, 19, 23) and with bilateral nephrectomy (18, 23) , suggesting that induction of inflammation and impaired cytokine clearance may each contribute to distant organ injury in the setting of acute kidney injury (33, 34) .
Our results extend those of the one previous study demonstrating that impaired kidney function, measured by an admission serum creatinine greater than 2 mg/dl, was associated with delirium during critical illness (24) . Whereas that study did not distinguish between acute and chronic kidney disease or examine the entire spectrum of acute kidney injury severity, we determined and adjusted for baseline kidney function and analyzed acute kidney injury in two ways (KDIGO stage and peak serum creatinine). Unlike acute kidney injury, baseline kidney function itself was not associated with delirium or coma. However, we did exclude patients with advanced chronic kidney disease and cannot therefore rule out a relationship between advanced chronic kidney disease and delirium or coma.
In analyses of both KDIGO stage and peak daily serum creatinine as risk factors for acute brain dysfunction, renal replacement therapy seemed to diminish the association in patients with the most severe acute kidney injury. One potential explanation for this interaction is that renal replacement therapy Comatose previous day Including RRT Figure 2 . Predicted probabilities of normal mental status versus delirium versus coma according to acute kidney injury by Kidney Disease Improving Global Outcomes (KDIGO) stage, stratified by mental status on the previous day. After adjusting for demographic factors, nonrenal organ failure, severe sepsis, and the previous day's mental status and sedative exposure, KDIGO stage was a significant risk factor for delirium and coma. The boxes show that as KDIGO stage rises (i.e., acute kidney injury severity increases), the predicted probability of normal mental status (green) falls, whereas the probabilities of delirium (blue) and coma (red) rise, with the overall probabilities of each mental state also depending on the mental state the previous day. itself lowers creatinine, making the latter a poor marker of acute kidney injury severity in these patients. Alternatively, the effects of renal replacement therapy may reduce the risk for delirium or coma due to acute kidney injury. One hypothesis, which needs to be tested, is that renal replacement therapy diminishes the effects of acute kidney injury on the brain by clearing sedatives, antibiotics, or other metabolites that may cause neurotoxicity (35) (36) (37) (38) . Another hypothesis to be examined is that preventing or reducing acute kidney injury, particularly when detected in its early stages, can attenuate the risk for abnormal mental status. Indeed, our findings confirm numerous studies demonstrating associations between sedatives (especially benzodiazepines) and delirium. Importantly, acute kidney injury was a significant risk factor for delirium and coma even after adjusting for sedative exposure, and we found no evidence of a statistical interaction between the severity of acute kidney injury and sedative use on the risk for delirium or coma. One reason for this lack of an interaction between acute kidney injury and sedative exposure may be that sedatives were used for just a few days in most participants, so our study may not be powered to rule out an interaction between the effects of acute kidney injury and sedatives on mental status. Thus, the lack of an interaction should not falsely reassure providers, who should keep in mind that some opiates or their metabolites (e.g., meperidine, morphine) and weakly active metabolites of some benzodiazepines (e.g., midazolam) are cleared by the kidney, so these drugs should be used with caution or avoided entirely in patients with acute kidney injury. When managing patients with impaired kidney function, ICU clinicians might choose to use fentanyl alone given that many ICU patients do not require sedation if pain is well controlled. For patients who do need more than analgesia, recent evidence suggests that certain sedatives (e.g., propofol) may reduce the risk of acute kidney injury (39) (40) (41) (42) .
Our findings also indicate that the previous day's mental status (which is influenced by all previously incurred risk factors for delirium and coma, including prior acute kidney injury, and can fluctuate often during critical illness) is strongly associated with current mental status. These results are intuitive and consistent with clinical experience and prior research (which, for example, has shown coma to be an important predictor of delirium). Notably, only a minority (14%) of observations were coma days given the short duration of coma for most patients, so the strong effect of previous coma did not influence most observations. Incorporating prior mental status added robustness to our examination of the association between acute kidney injury and mental status not performed in previous studies. More importantly, these findings highlight an association between acute brain dysfunction and acute kidney injury, a potentially modifiable risk factor, and suggest this association is of equal or greater impact than other than that seen with increasing age and sepsis, widely accepted as clinically relevant risk factors for delirium and coma.
Strengths of this study include the large sample with a diverse array of diagnoses, which improve generalizability; prospective, frequent assessment of mental status by highly trained staff using well-validated tools; use of a standardized, laboratorybased definition of acute kidney injury; collection and adjustment for detailed data on important potential confounders, including nonrenal organ failure and sedative use; and a statistical analysis that takes into account the temporal changes in exposure and outcomes. In addition, our findings persisted when we used an alternative definition for acute kidney injury (peak creatinine) and regardless of which approach we used to estimate baseline creatinine.
Limitations include the single-center population that excluded patients with overt neurologic disorders, which may limit ORIGINAL ARTICLE generalizability, and the possibility of residual confounding because our study was observational and cannot prove causality. For example, we did not account for the possibility of altered clearance of concomitant medications that may alter the metabolism of sedatives in the setting of acute kidney injury. We also did not have preadmission kidney function measures on all patients, although results remained similar throughout multiple sensitivity analyses. Because the number of patients who received renal replacement therapy was limited, we also could not analyze associations between the dose, timing, or modality of renal replacement therapy and delirium or coma in acute kidney injury. We are also limited by the precision of the assessments and definitions used to assess mental status and acute kidney injury, although these remain the current standard for clinical evaluation. Our transition model, for example, assumed that serum creatinine elevation observed on a given study day reflected a change in renal function during the prior 24 hours based on the wellestablished lag between injury and changes in serum creatinine (43, 44) . Although most ICU patients do have creatinine assessed at least once daily, it is possible that some acute kidney injury may have occurred on the same day that delirium or coma was assessed. Also, because the Sepsis-3 definition (45) was published after our study was completed, we used an older definition of sepsis that included systemic inflammatory response syndrome criteria and may have been insensitive to sepsis without systemic inflammatory response syndrome. Finally, the CAM-ICU and RASS are not designed to determine the etiology of delirium and coma. We did not distinguish disease-induced coma from drug-induced coma, nor did we identify rapidly reversible sedation-related delirium (which, in one recent study, affected 12% of patients similar to those in our cohort) (46) . Lack of precision in these measurements may have increased the noise in our dataset and biased our results toward the null hypothesis.
In conclusion, this large, prospective cohort study demonstrates that acute kidney injury is a significant risk factor for delirium and coma in adults with critical illness. Future studies are now needed to examine the mechanisms underlying these associations and the effects of processes of care (e.g., medications, renal replacement therapy) that may impact the risk of acute brain dysfunction in patients with acute kidney injury and the impact of reducing the incidence, severity, or duration of acute kidney injury on delirium or coma. n Author disclosures are available with the text of this article at www.atsjournals.org. Definition of abbreviations: CI = confidence interval; OR = odds ratio; RRT = renal replacement therapy; SOFA = Sequential Organ Failure Assessment. *Because of a significant interaction between RRT and peak serum creatinine today, the association between peak creatinine and mental status (normal vs. delirium vs. coma) differed according to the use of RRT. The associations between peak creatinine and mental status (normal vs. delirium vs. coma) are therefore reported here stratified according to whether RRT was present or not and modeled using the regression model predictors below. † Denotes a statistically significant association. ‡
In the full regression model, the regression coefficients (and corresponding ORs) for the associations between peak serum creatinine today and delirium and coma indicate the associations among patients not on RRT.
x Because of the significant interaction between RRT and peak serum creatinine today, the association between RRT and mental status (normal vs. delirium vs. coma) differed according to the change in creatinine. Results shown here assume a peak creatinine at the reference value (1 mg/dl). jj Compared with a reference (OR of 1.0) of "normal" mental status the previous day. Comatose previous day On RRT Figure 3 . Predicted probabilities of normal mental status versus delirium versus coma according to change from baseline in serum creatinine, stratified by mental status on the previous day and by renal replacement therapy (RRT). After adjusting for demographic factors, baseline serum creatinine, nonrenal organ failure, severe sepsis, and the previous day's mental status and sedative exposure, an increase in serum creatinine was a significant risk factor for delirium and coma. The solid lines show that as daily peak serum creatinine increases among patients not on RRT (A-C), the predicted probability of normal mental status (green) falls, whereas the probabilities of delirium (blue) and coma (red) rise, with the overall probabilities of each mental state also depending on the mental state the previous day. Alternatively, change in daily peak serum creatinine among patients on RRT (D-F) has no significant association with the predicted probability of mental status. Dashed lines indicate 95% confidence interval boundaries, and box plots on the x-axis indicate the distribution of peak serum creatinine (medians with interquartile range) according to previous day's mental status and use of RRT.
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